Reuters logo
Celgene posts higher quarterly profit
October 26, 2017 / 11:42 AM / a month ago

Celgene posts higher quarterly profit

Oct 26 (Reuters) - Celgene Corp said its third-quarter profit was nearly six times higher than a year ago, helped by a rise in sales of its multiple myeloma drug Revlimid as well as lower costs.

The U.S. biotechnology company’s net income rose to $988 million, or $1.21 per share, in the quarter ended Sept. 30, from $171 million, or 21 cents per share, a year earlier.

Revenue rose to $3.29 billion from $2.98 billion. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Savio D‘Souza)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below